Dr. Jorkasky is Chief Medical Officer and Head of Development at Complexa Therapeutics. She serves on the board of directors of OSE Therapeutics and is a member of the scientific advisory board of BioMotiv. Dr. Jorkasky has served as Chief Medical Officer at Endo Pharmaceuticals and Aileron Therapeutics. She has held executive appointments directing clinical research at Pfizer and SmithKline Beecham. She is on the medical school faculties of Yale University, University of Pennsylvania, the Uniformed Services University of Health Sciences and the University of California, San Francisco. Dr. Jorkasky is board certified in internal medicine, nephrology and clinical pharmacology and is an author of over 100 peer-reviewed publications.